Weight Distribution Asymmetry in Relation to Speed During Gait in Children With Spastic Cerebral Palsy.

Status

Completed

Phases

Study type

Interventional

Source

ClinicalTrials.gov

Registry ID

NCT04636424

Enrollment

114

Registered

2020-11-19

Start date

2019-12-03

Completion date

2020-11-01

Last updated

2020-11-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Gait, Spastic

Keywords

assymetry-gait-speed-cerebral palsy

Brief summary

Background: Improving walking ability is one of the major concerns in therapeutic interventions for children with cerebral palsy. Aim: determine the relation between the weight distributed on both lower limb and speed during walking.

Detailed description

sixty children with spastic diplegia (group A) and forty-five with hemiparesis ( group B) with age ranged from ten to twelve, they had spasticity grade 1 and 1+ according to modified ashworth scale and they were able to walk with assistance (level II on Gross Motor Classification System).Evaluation was held by the Biodex gait trainer for measuring weight distribution on both lower limbs and speed during gait to determine if there was a relation between weight distribution asymmetry and the speed of gait of those children

Interventions

OTHERassesment of gait

speed and weight distribution during gait

Study design

Allocation

NON_RANDOMIZED

Intervention model

PARALLEL

Primary purpose

OTHER

Masking

NONE

Eligibility

Sex/Gender

ALL

Age

10 Years to 12 Years

Healthy volunteers

Inclusion criteria

The selection criteria to the diplegic group were as follows: 1. children diagnosed as spastic diplegia or hemiplegia; 2. the ability to stand independently without support for not less than 30 seconds; 3. the ability to walk independently; a classification of level II in the Gross Motor Function Classification System (GMFCS); 4. and capability to understand simple verbal commands.

Exclusion criteria

1. Participants were excluded if they were treated for lower limbs orthopedic surgical or with botulinum toxin injection within the last 6 months 2. or if they had fixed lower limb deformity.

Design outcomes

Primary

Measure	Time frame	Description
speed of gait	12 weaks	the velocity of walking

Secondary

Measure	Time frame	Description
foot to foot distribution	12 weaks	weight loaded on each lower limb during gait assessment

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026